279 related articles for article (PubMed ID: 12490737)
1. Impact of tumor hypoxia and anemia on radiation therapy outcomes.
Harrison LB; Chadha M; Hill RJ; Hu K; Shasha D
Oncologist; 2002; 7(6):492-508. PubMed ID: 12490737
[TBL] [Abstract][Full Text] [Related]
2. Impact of anemia in patients with head and neck cancer treated with radiation therapy.
Hu K; Harrison LB
Curr Treat Options Oncol; 2005 Jan; 6(1):31-45. PubMed ID: 15610713
[TBL] [Abstract][Full Text] [Related]
3. Impact of anemia in patients with head and neck cancer.
Kumar P
Oncologist; 2000; 5 Suppl 2():13-8. PubMed ID: 10896324
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?
Harrison L; Blackwell K
Oncologist; 2004; 9 Suppl 5():31-40. PubMed ID: 15591420
[TBL] [Abstract][Full Text] [Related]
5. The negative impact of anemia on radiotherapy and chemoradiation outcomes.
Shasha D
Semin Hematol; 2001 Jul; 38(3 Suppl 7):8-15. PubMed ID: 11523023
[TBL] [Abstract][Full Text] [Related]
6. Anemia, tumor hypoxemia, and the cancer patient.
Varlotto J; Stevenson MA
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):25-36. PubMed ID: 16111569
[TBL] [Abstract][Full Text] [Related]
7. Tumor hypoxia and anemia: impact on the efficacy of radiation therapy.
Kumar P
Semin Hematol; 2000 Oct; 37(4 Suppl 6):4-8. PubMed ID: 11068949
[TBL] [Abstract][Full Text] [Related]
8. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
Vordermark D; Brown JM
Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
[TBL] [Abstract][Full Text] [Related]
10. Oxygen-modifying treatment with ARCON reduces the prognostic significance of hemoglobin in squamous cell carcinoma of the head and neck.
Hoogsteen IJ; Pop LA; Marres HA; Merkx MA; van den Hoogen FJ; van der Kogel AJ; Kaanders JH
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):83-9. PubMed ID: 16213107
[TBL] [Abstract][Full Text] [Related]
11. Chemoradiation for advanced head and neck cancer: potential for improving results to match those of current treatment modalities for early-stage tumors--long-term results of hyperfractionated chemoradiation with carbogen breathing and anemia correction with erythropoietin.
Villar A; Martinez JC; de Serdio JL
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1382-8. PubMed ID: 18037586
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of reoxygenation in advanced cancer of the head and neck during the initial course of chemoradiation or radiotherapy alone.
Dietz A; Vanselow B; Rudat V; Conradt C; Weidauer H; Kallinowski F; Dollner R
Head Neck; 2003 Jan; 25(1):50-8. PubMed ID: 12478544
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer.
Prosnitz RG; Yao B; Farrell CL; Clough R; Brizel DM
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1087-95. PubMed ID: 15752888
[TBL] [Abstract][Full Text] [Related]
14. Treatment resistance of solid tumors: role of hypoxia and anemia.
Vaupel P; Thews O; Hoeckel M
Med Oncol; 2001; 18(4):243-59. PubMed ID: 11918451
[TBL] [Abstract][Full Text] [Related]
15. Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies.
Bache M; Kappler M; Said HM; Staab A; Vordermark D
Curr Med Chem; 2008; 15(4):322-38. PubMed ID: 18288988
[TBL] [Abstract][Full Text] [Related]
16. Impact of hemoglobin levels on tumor oxygenation: the higher, the better?
Vaupel P; Mayer A; Höckel M
Strahlenther Onkol; 2006 Feb; 182(2):63-71. PubMed ID: 16447012
[TBL] [Abstract][Full Text] [Related]
17. Targeting hypoxia to overcome radiation resistance in head & neck cancers: real challenge or clinical fairytale?
Baumann R; Depping R; Delaperriere M; Dunst J
Expert Rev Anticancer Ther; 2016 Jul; 16(7):751-8. PubMed ID: 27253509
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
Chaplin DJ; Horsman MR; Aoki DS
Br J Cancer; 1991 Jan; 63(1):109-13. PubMed ID: 1846549
[TBL] [Abstract][Full Text] [Related]
19. rHuEPO and treatment outcomes: the preclinical experience.
Ludwig H
Oncologist; 2004; 9 Suppl 5():48-54. PubMed ID: 15591422
[TBL] [Abstract][Full Text] [Related]
20. Improved recurrence-free survival with ARCON for anemic patients with laryngeal cancer.
Janssens GO; Rademakers SE; Terhaard CH; Doornaert PA; Bijl HP; van den Ende P; Chin A; Takes RP; de Bree R; Hoogsteen IJ; Bussink J; Span PN; Kaanders JH
Clin Cancer Res; 2014 Mar; 20(5):1345-54. PubMed ID: 24452791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
